These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9532592)
1. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system. Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592 [TBL] [Abstract][Full Text] [Related]
2. Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment. Trojano M; Avolio C; Ruggieri M; Defazio G; Giuliani F; Paolicelli D; Livrea P Mult Scler; 1998 Jun; 4(3):183-7. PubMed ID: 9762671 [TBL] [Abstract][Full Text] [Related]
3. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings. Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741 [TBL] [Abstract][Full Text] [Related]
4. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Jander S; Heidenreich F; Stoll G Neurology; 1993 Sep; 43(9):1809-13. PubMed ID: 8105425 [TBL] [Abstract][Full Text] [Related]
5. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. Droogan AG; McMillan SA; Douglas JP; Hawkins SA J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061 [TBL] [Abstract][Full Text] [Related]
6. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752 [TBL] [Abstract][Full Text] [Related]
7. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone. Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901 [TBL] [Abstract][Full Text] [Related]
8. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis. Vedeler CA; Matre R; Sadallah S; Schifferli J J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926 [TBL] [Abstract][Full Text] [Related]
9. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment. Kilinc M; Saatci-Cekirge I; Karabudak R J Interferon Cytokine Res; 2003 Mar; 23(3):127-33. PubMed ID: 12716484 [TBL] [Abstract][Full Text] [Related]
10. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353 [TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases. Heidenreich F; Arendt G; Jander S; Jablonowski H; Stoll G J Neuroimmunol; 1994 Jul; 52(2):117-26. PubMed ID: 7913474 [TBL] [Abstract][Full Text] [Related]
12. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785 [TBL] [Abstract][Full Text] [Related]
13. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome. Patzold T; Sindern E; Ossege-Pohle L; Malin JP J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Tsukada N; Matsuda M; Miyagi K; Yanagisawa N Neurology; 1993 Dec; 43(12):2679-82. PubMed ID: 8255476 [TBL] [Abstract][Full Text] [Related]
15. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430 [TBL] [Abstract][Full Text] [Related]
16. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index. Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518 [TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1 in cerebrospinal fluid--the evaluation of blood-derived and brain-derived fractions in neurological diseases. Lewczuk P; Reiber H; Tumani H J Neuroimmunol; 1998 Jul; 87(1-2):156-61. PubMed ID: 9670857 [TBL] [Abstract][Full Text] [Related]
19. Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. Rieckmann P; Nünke K; Burchhardt M; Albrecht M; Wiltfang J; Ulrich M; Felgenhauer K J Neuroimmunol; 1993 Sep; 47(2):133-40. PubMed ID: 8103775 [TBL] [Abstract][Full Text] [Related]
20. Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis. Kraus J; Bauer R; Chatzimanolis N; Engelhardt B; Tofighi J; Bregenzer T; Kuehne BS; Stolz E; Blaes F; Morgen K; Traupe H; Kaps M; Oschmann P J Neurol; 2004 Apr; 251(4):464-72. PubMed ID: 15083294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]